New evidence demonstrates link between smoking, prostate cancer prognosis
the ONA take:
The association between smoking and the development of various forms of cancer are well established; however, evidence of such a link with prostate cancer is contradictory.
Now, an international study led by MedUni Vienna and Basle University Hospital has found evidence of a clear link.
The study combined data on 7,191 patients with prostate cancer who underwent radical prostatectomy, with no preoperative treatments.
The results showed that risk of biochemical recurrence of prostate for smokers and ex-smokers was twice that of nonsmokers. However, this negative effect can be offset within 10 years of quitting.
Although this research still does not clarify, in scientific terms, whether smoking is associated with the development of prostate cancer, it does demonstrate that smoking increases the risk of dying from the disease.
The researchers acknowledge that further research is needed, but stress the significance of quitting smoking even for those who are already suffering from prostate cancer.
Association between smoking and development of various forms of cancer well established; however, evidence of prostate cancer link contradictory.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|